Tech Company Financing Transactions

RadPharm Funding Round

Siemens Venture Capital, Adams Harkness Ventures and Amidzad Partners participated in a $10 million Series B funding round for RadPharm. The round was announced on 11/29/2007.

Transaction Overview

Company Name
RadPharm
Announced On
11/29/2007
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors

Siemens Venture Capital (Lead Investor) (Andrew Jay)

Adams Harkness Ventures

Amidzad Partners (Herbert Hooper)

Proceeds Purpose
Ronald A. Berg, President and CEO of RadPharm said, "This financing marks another key milestone for RadPharm in a year that has included strong growth in revenues and backlog, the opening of an office in Munich, and further expansion of RadPharm's customer base. As a global organization that has provided image review services for over 60 sponsors and 250 clinical trials, and with the additional capital provided by this financing, RadPharm is well-positioned to continue expanding its offering of core laboratory services for drug development."

Company Information

Company Status
Acquired or Merged
Industry
Healthcare Services
Mailing Address
100 Overlook Center
Princeton, NJ 08540
USA
Phone
(877) 632-9432
Website
www.radpharm.com
Email Address
[email protected]
Overview
RadPharm integrates expertise in medical imaging and drug development to enable the more rapid development of breakthrough treatments for cancer and other diseases.
Profile
RadPharm LinkedIn Company Profile
Social Media
RadPharm Company Twitter Account
Company News
RadPharm News
Facebook
RadPharm on Facebook
YouTube
RadPharm on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ronald Berg
  Ronald Berg LinkedIn Profile  Ronald Berg Twitter Account  Ronald Berg News  Ronald Berg on Facebook
Chief Financial Officer
Denis Manginelli
  Denis Manginelli LinkedIn Profile  Denis Manginelli Twitter Account  Denis Manginelli News  Denis Manginelli on Facebook
Chief Information Officer
Steven Owens
  Steven Owens LinkedIn Profile  Steven Owens Twitter Account  Steven Owens News  Steven Owens on Facebook
Chief Medical Officer
Robert Ford
  Robert Ford LinkedIn Profile  Robert Ford Twitter Account  Robert Ford News  Robert Ford on Facebook
Chief Technical Officer
David Clunie
  David Clunie LinkedIn Profile  David Clunie Twitter Account  David Clunie News  David Clunie on Facebook
Vice President
John O'Neal
  John O'Neal LinkedIn Profile  John O'Neal Twitter Account  John O'Neal News  John O'Neal on Facebook
Vice President
Eric Perlman
  Eric Perlman LinkedIn Profile  Eric Perlman Twitter Account  Eric Perlman News  Eric Perlman on Facebook
VP - Marketing
Kevin Duffy
  Kevin Duffy LinkedIn Profile  Kevin Duffy Twitter Account  Kevin Duffy News  Kevin Duffy on Facebook
VP - Operations
James Golando
  James Golando LinkedIn Profile  James Golando Twitter Account  James Golando News  James Golando on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/29/2007: Fate Therapeutics venture capital transaction
Next: 11/29/2007: Vubiquity venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.